Risk of non-Hodgkin lymphoma and use of non-steroidal anti-inflammatory drugs

Cancer Detection and Prevention

Volumn 30, Issue 1, 2006, Pages 99-101

  Zhang, Yuqing ^a   Coogan, Patricia F ^b   Palmer, Julie R ^b   Strom, Brian L ^c   Rosenberg, Lynn ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Case control studies; Non Hodgkin lymphoma; Non steroidal anti inflammatory drug; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; ODDS RATIO; POPULATION SURVEILLANCE; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS;

EID: 33644867203     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2005.12.002     Document Type: Article

References (21)

1. F.D. Groves, M.S. Linet, L.B. Travis, and S.S. Devesa Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995 J Natl Cancer Inst 92 2000 1240 1251
2. R.A. Cartwright, P.A. McKinney, and C. O'Brien Non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire Leuk Res 12 1988 81 88
3. L. Bernstein, and R.K. Ross Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County Cancer Res 52 1992 5510s 5515s
4. M.J. Thun, M.M. Namboodiri, E.E. Calle, W.D. Flanders, and C.W. Heath Jr. Aspirin use and risk of fatal cancer Cancer Res 53 1993 1322 1327
5. E.A. Holly, C. Lele, P.M. Bracci, and M.S. McGrath Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California Am J Epidemiol 150 1999 375 389
6. I. Kato, K.L. Koenig, and R.E. Shore Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States) Cancer Causes Control 13 2002 965 974
7. J.R. Cerhan, K.E. Anderson, C.A. Janney, C.M. Vachon, T.E. Witzig, and T.M. Habermann Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma Int J Cancer 106 2003 784 788
8. Y. Zhang, T.R. Holford, and B. Leaderer Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women Cancer Causes Control 15 2004 419 428
9. L. Rosenberg Nonsteroidal anti-inflammatory drugs and cancer Prev Med 24 1995 107 109
10. L. Rosenberg, C. Louik, and S. Shapiro Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma Cancer 82 1998 2326 2333
11. P.F. Coogan, S.R. Rao, and L. Rosenberg The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer Prev Med 29 1999 72 76
12. P.F. Coogan, L. Rosenberg, and J.R. Palmer Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel Cancer Epidemiol Biomarkers Prev 9 2000 119 123
13. P.F. Coogan, L. Rosenberg, and C. Louik NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease Cancer Causes Control 11 2000 249 255
14. L. Rosenberg, J.R. Palmer, and R.S. Rao A case-control study of analgesic use and ovarian cancer Cancer Epidemiol Biomarkers Prev 9 2000 933 937
15. Y. Zhang, P.F. Coogan, J.R. Palmer, B.L. Strom, and L. Rosenberg Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited Am J Epidemiol 162 2005 165 170
16. L. Mellemkjaer, M.S. Linet, G. Gridley, M. Frisch, H. Moller, and J.H. Olsen Rheumatoid arthritis and cancer risk Eur J Cancer 32A 1996 1753 1757
17. G. Gridley, J.K. McLaughlin, and A. Ekbom Incidence of cancer among patients with rheumatoid arthritis J Natl Cancer Inst 85 1993 307 311
18. E. Baecklund, A. Ekbom, P. Sparen, N. Feltelius, and L. Klareskog Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study BMJ 317 1998 180 181
19. L. Rosenberg, J.R. Palmer, A.G. Zauber, M.E. Warshauer, P.D. Stolley, and S. Shapiro A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer J Natl Cancer Inst 83 1991 355 358
20. M.M. Taketo Cyclooxygenase-2 inhibitors in tumorigenesis (part I) J Natl Cancer Inst 90 1998 1529 1536
21. M.K. Jones, H. Wang, and B.M. Peskar Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing Nat Med 5 1999 1418 1423